ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Song Gao
Matched on ORCID iD 0009-0001-5287-2113; OpenAlex author ID A5030731769. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 30
2024: 3 papers · 2025: 2 papers · 2026: 1 paper
Papers 6
- Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-25-0323↗
- CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway. Co-author DOI 10.20892/j.issn.2095-3941.2025.0058↗
- Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters. Co-author DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer. Last author DOI 10.1515/med-2023-0893↗
- Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma. Co-author DOI 10.20892/j.issn.2095-3941.2023.0363↗
- Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. Last author DOI 10.20892/j.issn.2095-3941.2024.0036↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jihui Hao · 4 shared papers, 2024–2026 · strength 0.84
- Paper Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biolo… DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036↗
- Paper Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ducta… DOI 10.20892/j.issn.2095-3941.2023.0363↗
- Yuexiang Liang · 3 shared papers, 2024–2026 · strength 0.63
- Paper Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biolo… DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Paper Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ducta… DOI 10.20892/j.issn.2095-3941.2023.0363↗
- Paper Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer. DOI 10.1158/2159-8290.cd-25-0323↗
- Xiuchao Wang · 3 shared papers, 2025–2026 · strength 0.60
- Paper Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biolo… DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Paper Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer. DOI 10.1158/2159-8290.cd-25-0323↗
- Paper CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway. DOI 10.20892/j.issn.2095-3941.2025.0058↗
- Tiansuo Zhao · 3 shared papers, 2025–2026 · strength 0.60
- Paper Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biolo… DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Paper Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer. DOI 10.1158/2159-8290.cd-25-0323↗
- Paper CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway. DOI 10.20892/j.issn.2095-3941.2025.0058↗
- Quan Man · 2 shared papers, 2024–2025 · strength 0.44
- Paper Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biolo… DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Paper Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ducta… DOI 10.20892/j.issn.2095-3941.2023.0363↗
- Yiping Zou · 2 shared papers, 2024–2025 · strength 0.44
- Paper Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biolo… DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Paper Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ducta… DOI 10.20892/j.issn.2095-3941.2023.0363↗
- Shaofei Chang · 2 shared papers, 2024–2025 · strength 0.44
- Paper Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biolo… DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Paper Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ducta… DOI 10.20892/j.issn.2095-3941.2023.0363↗
- Jun Yu · 2 shared papers, 2025–2026 · strength 0.42
- Paper Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biolo… DOI 10.20892/j.issn.2095-3941.2025.0213↗
- Paper Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer. DOI 10.1158/2159-8290.cd-25-0323↗
- Guannan Sheng · 2 shared papers, 2024–2025 · strength 0.39
- Paper Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ducta… DOI 10.20892/j.issn.2095-3941.2023.0363↗
- Paper CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway. DOI 10.20892/j.issn.2095-3941.2025.0058↗
- Tianxing Zhou · 2 shared papers, 2025–2026 · strength 0.37
- Shuai Yuan · 1 shared paper, 2024 · strength 0.28
- Jie Xu · 1 shared paper, 2024 · strength 0.28
- Song Gao · 1 shared paper, 2025 · strength 0.23
- Wenbo Zhu · 1 shared paper, 2024 · strength 0.22
- Xingyun Chen · 1 shared paper, 2024 · strength 0.22
- Jing Huang · 1 shared paper, 2024 · strength 0.22
- Xiaofan Guo · 1 shared paper, 2024 · strength 0.22
- Yuxiao Liu · 1 shared paper, 2024 · strength 0.22
- Meng Zhang · 1 shared paper, 2026 · strength 0.19
- Xiao Hu · 1 shared paper, 2026 · strength 0.19
- Chuntao Gao · 1 shared paper, 2026 · strength 0.19
- Shangheng Shi · 1 shared paper, 2026 · strength 0.19
- Shengyu Yang · 1 shared paper, 2025 · strength 0.18
- Chunhua She · 1 shared paper, 2025 · strength 0.18
- Liangliang Wu · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.